194 related articles for article (PubMed ID: 23042516)
1. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.
Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP
Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516
[No Abstract] [Full Text] [Related]
2. Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.
Ramírez del Pozo ME; Contreras Contreras E; López Tiro J; Gómez Vera J
J Investig Allergol Clin Immunol; 2011; 21(5):416-7. PubMed ID: 21905512
[No Abstract] [Full Text] [Related]
3. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
[No Abstract] [Full Text] [Related]
4. Sequential combined therapy with omalizumab and rituximab: a new approach to severe atopic dermatitis.
Sánchez-Ramón S; Eguíluz-Gracia I; Rodríguez-Mazariego ME; Paravisini A; Zubeldia-Ortuño JM; Gil-Herrera J; Fernández-Cruz E; Suárez-Fernández R
J Investig Allergol Clin Immunol; 2013; 23(3):190-6. PubMed ID: 23967758
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab treatment in severe adult atopic dermatitis.
Thaiwat S; Sangasapaviliya A
Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases.
Toledo F; Silvestre JF; Muñoz C
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1325-7. PubMed ID: 22050044
[No Abstract] [Full Text] [Related]
7. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
Amrol D
South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a bullous urticaria with omalizumab.
Ozturk AB; Kocaturk E; Ozturk E
Allergol Int; 2014 Sep; 63(3):495-7. PubMed ID: 24957115
[No Abstract] [Full Text] [Related]
9. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
10. Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab.
von Websky A; Reich K; Steinkraus V; Breuer K
J Dtsch Dermatol Ges; 2013 Jul; 11(7):677-8. PubMed ID: 23575040
[No Abstract] [Full Text] [Related]
11. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
12. Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI.
Forman SB; Garrett AB
Cutis; 2007 Jul; 80(1):38-40. PubMed ID: 17725062
[TBL] [Abstract][Full Text] [Related]
13. Unanswered clinical questions and speculation about the role of anti-immunoglobulin E in atopic and nonatopic disease.
Lanier B
Allergy Asthma Proc; 2006; 27(2 Suppl 1):S37-42. PubMed ID: 16722331
[TBL] [Abstract][Full Text] [Related]
14. Severe refractory atopic dermatitis with elevated serum IgE treated with omalizumab.
Switlyk SA; Taylor AL; Gaertner EM
Cutis; 2017 Apr; 99(4):E6-E8. PubMed ID: 28492605
[No Abstract] [Full Text] [Related]
15. Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study.
Dal Negro RW; Guerriero M; Micheletto C; Tognella S; Visconti M
J Asthma; 2011 Jun; 48(5):437-41. PubMed ID: 21599560
[TBL] [Abstract][Full Text] [Related]
16. Successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy.
Cavelti-Weder C; Muggli B; Keller C; Babians-Brunner A; Biason-Lauber A; Donath MY; Schmid-Grendelmeier P
Diabetes Care; 2012 Jun; 35(6):e41. PubMed ID: 22619293
[No Abstract] [Full Text] [Related]
17. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
18. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
Özgür ES; Özge C; Ïlvan A; Naycı SA
J Asthma; 2013 Aug; 50(6):687-94. PubMed ID: 23557459
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab for patients with severe and therapy-refractory atopic eczema?
Andres C; Belloni B; Mempel M; Ring J
Curr Allergy Asthma Rep; 2008 May; 8(3):179-80. PubMed ID: 18589835
[No Abstract] [Full Text] [Related]
20. Atopic dermatitis is an important comorbidity in severe asthma.
Lee JK; Han D
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
